New Zealand nootropic company Ārepa is investing over NZ$2 million (US$1.4m) on a series of brain health and performance clinical trials as it looks to create the world’s smartest drink.
Atlanta-based Synape announced that the start-up has raised $1 million in funding, with investors including beverage industry executives, medical professionals, convenience retail executives, and other private investors in the CPG space.